CA Healthcare Acquisition Corp.
We intend to capitalize on our management team’s differentiated ability to source, acquire, and manage a business in the healthcare industry, specifically healthcare services, healthcare information technology, care management, behavioral health, medical devices, diagnostics, pharma services, health and wellness, and specialty pharmacy.
(Note: CA Healthcare Acquisition priced its IPO on Jan. 26, 2021, according to the terms in the prospectus: 10 million units at $10 to raise $100 million. On April 7, 2021, CA Healthcare Acquisition announced that it had entered into a definitive agreement to combine with LumiraDx, a COVID-19 testing company and medical device maker, in a deal with an enterprise value of $5 billion. LumiraDx withdrew its IPO on or about April 7, 2021.)
|Address||99 Summer Street Suite 200 Boston, MA 02110|
|Phone Number||(617) 314-3901|
|View Prospectus:||CA Healthcare Acquisition Corp.|
|Revenues||$0 mil (last 12 months)|
|Net Income||$0 mil (last 12 months)|
|Price range||$10.00 - $10.00|
|Est. $ Volume||$100.0 mil|
|Manager / Joint Managers||BTIG|
|Expected To Trade:||1/27/2021|
|Quiet Period Expiration Date:||Available only to Subscribers|
|Lock-Up Period Expiration Date:||Available only to Subscribers|
|SCOOP Rating||Available only to Subscribers|
|Rating Change||Available only to Subscribers|